The Center for Translational Pain Medicine (CTPM) is transforming the way we study, diagnose, and treat painful conditions. The CTPM brings together, under one umbrella, a diverse team of basic science and clinical researchers with complementary expertise in pain neurobiology, molecular genetics, neuroimaging, epidemiology, and bioinformatics to make exciting new discoveries in the areas of pain mechanisms and management. The CTPM extends into Duke Anesthesiology’s clinical innovative pain therapy program to achieve a common core mission of improving patient care.
Incorporating basic science, clinical research and pain management with three primary goals:
Updates & Announcements
Duke Anesthesiology Awarded Program Project Grant
Two CTPM Faculty Awarded a 2020 DREAM Innovation Grant
Pain Journal Club
First Friday of the month
12 – 1 PM | GSRBIII 6130
Stay up-to-date on the latest pain-related news, research & events:
USASP | IASP | NIH Pain Consortium | Pain Research Forum
Tradition • Innovation • Translation
CTPM News
Postdoctoral Fellow Awarded Alzheimer's Association Research Fellowship
Congratulations to Dr. ChengCheng Song of the Terrando lab on receiving a highly competitive $199,969 grant for her project aimed at understanding the long-term impact of postoperative delirium on Alzheimer’s disease hallmarks.
Some E-Cigarette Chemicals Mimic Nicotine, Possibly Bypassing Regulation
A new publication in JAMA, co-authored by Duke Anesthesiology’s Drs. Sven-Eric Jordt and Sairam Jabba, finds that some tobacco companies are replacing nicotine in e-cigarettes with related chemicals to apparently bypass health regulations with inaccurate disclosure of the quantity on packaging.
Duke Announces 2024 Distinguished Professors
Congratulations to Duke Anesthesiology’s Dr. Miriam Treggiari, the Paul G. Barash Professor of Anesthesiology, on being among the 32 faculty awarded a distinguished professorship at Duke University for demonstrating extraordinary scholarship in advancing science and improving human health.
Early Identification of Persistent Pain + Holistic Interventions Cut Opioid Use
A newly-published study in the New England Journal of Medicine Catalyst, led by Duke Anesthesiology’s Dr. Padma Gulur, finds that a simple two-question survey can identify who could benefit the most from a holistic approach to managing pain.
Menthol Ban Looming, Cigarette Makers Turn to Synthetic Substitutes
Newly-published research in JAMA, led by Duke Anesthesiology’s Drs. Sairam Jabba and Sven-Eric Jordt, reveals the additives in “non-menthol” cigarettes are designed to mimic the effects of menthol, facilitating smoking initiation.
Dr. Ji Awarded NIH Grant to Study Checkpoint Inhibitors for Pain Control
Congratulations to Ru-Rong Ji, PhD, on receiving a three year $2,569,851 grant from the National Institutes of Health for research aimed at providing novel insights into distinct actions of checkpoint pathway activators and inhibitors for the management of different types of pain.
Dr. Nackley Awarded NIH Grant for Innovative Pain Therapy Research
Congratulations to Andrea Nackley, PhD, on receiving a two-year $1,846,202 R61 grant to develop novel Adrb3 antagonists for the treatment of chronic primary pain conditions as part of the NIH’s Helping to End Addiction Long-term (HEAL) Initiative.
Dr. Gulur Earns Prestigious Innovation Award
Congratulations to Padma Gulur, MD, on receiving the Harwick Innovation Award from the Medical Group Management Association for her development of the Anesthesia Resource Management System – an innovative approach to optimize anesthesia resources through a utilization-based model.
Dr. Bang Awarded NIH Grant for Craniofacial Pain Research
Congratulations to Sangsu Bang, PhD, on receiving a $322,000 R03 grant from the National Institutes of Health for his project that proposes a novel molecular mechanism for the resolution of tertiary pain, ultimately advancing the understanding of how neurogenic inflammation is controlled.
Faculty, Fellow Awarded NIH Grant for Chronic Pain Study
Congratulations to Drs. Andrea Nackley and Nathaniel Hernandez (fellow), on receiving a $128,409 fellowship grant from the National Institutes of Health for their project aimed at advancing the understanding of the epigenetic basis for chronic primary pain conditions and elucidating new therapeutic targets.